The caspase-3 activity in doxorubicin-treated tumor xenografts is studied by positron emission tomography (PET) using a novel 18F-labeled caspase-3-sensitive nanoaggregation tracer. In their Communication on page 10511 ff., J. Rao, F. T. Chin, et al. show that the enzyme-activatable tracer improves the PET imaging of apoptotic tumors by intramolecular macrocyclization and in situ aggregation of the cyclized tracer upon caspase-3 activation. (Picture: Jim Strommer and Lydia-Marie Joubert.)